Appendix 1

Members of the joint Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) and Intergovernmental Committee on HIV/AIDS, Hepatitis C and Related Diseases In 2006, the Intergovernmental Committee on AIDS, Hepatitis and Related Diseases was replaced by the Blood Borne Virus and Sexually Transmissible Infections Subcommittee of the Australian Population Health Development Principal Committee. (IGCAHRD) Prisons Working Group


Professor Robert Batey AM. Chair of the Hepatitis C Subcommittee of MACASHH


Ms Judith Wheeldon
Ms Annie Madden, Australian Injecting & Illicit Drug Users League
Mr Stuart Loveday, Australian Hepatitis Council
Ms Kim Stewart, Chair of the former Intergovernmental Committee on HIV/AIDS, Hepatitis C and Related Diseases and member of the Blood Borne Virus and Sexually Transmissible Infections Subcommittee
Mr Gino Vumbaca, Australian National Council on Drugs (ANCD)
Associate Professor Michael Levy, Centre for Health Research in Criminal Justice (CHRCJ)
Mr Michael Doyle, Aboriginal Health Council
Commissioner Kelvin Anderson, Commissioner, Corrective Services Administrators Conference (CSAC) Victorian Office of the Custodial Services
Shani Prosser, Population Health Justice Health, NSW Long Bay Custodial Complex

Top of Page

Appendix 2

The principles which underlie this strategy use the framework established by the National Hepatitis C Strategy 2005-2008.

These are:
  1. Health promotion, which is the process of enabling people to increase control over, and to improve, their health.
  2. Partnership between people with hepatitis C, inmates, custodial authorities, health authorities, community-based organisations, researchers and.
  3. A social determinants model which recognises that inmates are disproportionately affected by all forms of social disadvantage and have reduced capacity to manage their own health.
  4. Equity of access for inmates to evidence-based responses to hepatitis C prevention, education, treatment, care, and support, commensurate to that offered in the community.
  5. Participation in the development and delivery of treatment, care, support, prevention and education strategies by inmates with hepatitis C.
  6. Harm reduction – which does not condone illegal behaviours such as illicit drug use - but, consistent with the framework established by the National Drug Strategy (ref), refers to policies and programs aimed at reducing drug related harm. Harm reduction interventions aim to improve health, social and economic outcomes for individual inmates, others in the custodial setting and the community generally as part of a continuum which also includes supply reduction and demand reduction.

Key Supporting Documents Include:
  • The National Hepatitis C Strategy 2005 - 2008 (The Australian Government Department of Health and Ageing);
  • The National Aboriginal and Torres Strait Islanders’ Sexual Health and Blood Borne Virus Strategy 2005 – 2008 (The Australian Government Department of Health and Ageing);
  • Model of Care for the Management of Hepatitis C Infection in Adults 2003 (Australian National Council on AIDS, Hepatitis C and Related Diseases);
  • National Hepatitis C Testing Policy, 2003 (Australian National Council on AIDS, Hepatitis C and Related Diseases);
  • Infection Control Guidelines: for the prevention of transmission of infectious diseases in the health care setting, 2004 (The Australian Government Department of Health and Ageing)
  • Supply Demand and Harm Reduction Strategies in Australian Prisons,2004 (Australian National Council on Drugs);
  • ANCAHRD Bulletin Number 19 HIV, Hepatitis and Other Blood Borne Viruses in Sport, June 2001 (Australian Government Department of Health and Ageing).
Top of Page

Appendix 3 – Infection Control

The following have been developed from the Infection Control Guidelines for the Prevention of Infections Diseases in the Health Care Setting 2004.

The key aspects of infection control that apply to the custodial setting include:
  • Adoption of standard precautions which assume that anyone is likely to have a blood borne virus (BBV) and therefore adopt procedures that minimise the risk of infection via the exchange of blood and body fluids, and that staff use protective attire (gloves etc) when they are likely to encounter blood.
  • Identification of the specific infection control hazards relating to Custodial facilities and development of policies and procedures to manage those risks.
  • Provision of appropriate equipment and supplies to support hygienic practices.
  • Ready availability of a "spills kit" to deal with exposure incident.
  • Specific procedures in place for managing any blood exposure: this will include a system for immediate assessment of the infectious status of the sources and exposure as well as provision for cleaning and expert assessment about the risks and feasibility of treatments and their documentation. Details are given in the Infection Control Guidelines (
  • Waste management systems that prevent the possibility of exposure incidents that may occur including "sharps" injuries and provide for the personal hygienic of females and the appropriate management of menstrual female sanitary items.
  • Adoption of AS/NZS 4187 standards for cleaning, disinfecting and sterilizing of reusable medical and surgical instruments and equipment and maintenance of associated environments in health care settings by Custodial health services.
  • Surveillance and documentation of BBV infections acquired and evidence that specific strategies are implemented to diminish factors that lead to such infections.
  • Education about these guidelines and their local application and implementation should be provided to inmates and staff in routine induction and professional development activities.